Back to all articles

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative

06 February 2026

In this post

In case you missed it, Fierce Biotech covered our pioneering AI-powered lung cancer diagnostic initiative with the NHS.

This is the first NHS project to combine our AI-powered lung nodule risk stratification & management platform (Virtual Nodule Clinic) with robotic-assisted bronchoscopy. This programme is designed to help clinicians diagnose lung cancer earlier, more accurately, and to minimise invasive procedures.

Read the full article here

19 August 2026 / Uncategorized

Optellum Virtual Nodule Clinic (VNC) vs. RevealDx RevealAI-Lung

Incidental lung nodule care requires more than a one-time risk output. Thoracic programs are multidisciplinary teams comprising pulmonologists, radiologists,...

17 May 2026 / Uncategorized

Lung nodule care doesn't stop at the radiology report. So why should the AI?

Incidental lung nodules are managed by multidisciplinary teams, not one specialty alone. Our LCP AI remains the only FDA-cleared AI risk stratification solution indicated for both pulmonologists and r

08 May 2026 / Uncategorized

Meet the Thoracic Champion series: An interview with Samantha Otis, NP-C at Wellstar MCG Health Medical Center in Augusta, Georgia

My name is Samantha Otis and I am a Nurse Practitioner working with MCG's Lung Cancer Screening Program. I get the opportunity to see patients in clinic through their journey, from discovery to treatm

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative

In this post

Related Articles

Optellum Virtual Nodule Clinic (VNC) vs. RevealDx RevealAI-Lung

Lung nodule care doesn't stop at the radiology report. So why should the AI?

Meet the Thoracic Champion series: An interview with Samantha Otis, NP-C at Wellstar MCG Health Medical Center in Augusta, Georgia